Regulation of T-Cell Immune Responses by Pro-Resolving Lipid Mediators

Both the initiation and the resolution of inflammatory responses are governed by the sequential activation, migration, and control/suppression of immune cells at the site of injury. Bioactive lipids play a major role in the fine-tuning of this dynamic process in a timely manner. During inflammation...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Javier Perez-Hernandez, Valerio Chiurchiù, Sylvain Perruche, Sylvaine You
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/8c9b52be948d4ead82a8151922b16622
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:8c9b52be948d4ead82a8151922b16622
record_format dspace
spelling oai:doaj.org-article:8c9b52be948d4ead82a8151922b166222021-11-16T07:32:02ZRegulation of T-Cell Immune Responses by Pro-Resolving Lipid Mediators1664-322410.3389/fimmu.2021.768133https://doaj.org/article/8c9b52be948d4ead82a8151922b166222021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fimmu.2021.768133/fullhttps://doaj.org/toc/1664-3224Both the initiation and the resolution of inflammatory responses are governed by the sequential activation, migration, and control/suppression of immune cells at the site of injury. Bioactive lipids play a major role in the fine-tuning of this dynamic process in a timely manner. During inflammation and its resolution, polymorphonuclear cells (PMNs) and macrophages switch from producing pro-inflammatory prostaglandins and leukotrienes to specialized pro-resolving lipid mediators (SPMs), namely, lipoxins, resolvins, protectins, and maresins, which are operative at the local level to limit further inflammation and tissue injury and restore homeostasis. Accumulating evidences expand now the role and actions of these lipid mediators from innate to adaptive immunity. In particular, SPMs have been shown to contribute to the control of chronic inflammation, and alterations in their production and/or function have been associated with the persistence of several pathological conditions, including autoimmunity, in human and experimental models. In this review, we focus on the impact of pro-resolving lipids on T cells through their ability to modulate T-cell responses. In particular, the effects of the different families of SPMs to restrain effector T-cell functions while promoting regulatory T cells will be reviewed, along with the underlying mechanisms. Furthermore, the emerging concept of SPMs as new biological markers for disease diagnostic and progression and as putative therapeutic tools to regulate the development and magnitude of inflammatory and autoimmune diseases is discussed.Javier Perez-HernandezJavier Perez-HernandezValerio ChiurchiùValerio ChiurchiùSylvain PerrucheSylvain PerrucheSylvaine YouFrontiers Media S.A.articleresolutionadaptive immunityautoimmunityT celltherapyspecialized pro-resolving lipid mediators (SPMs)Immunologic diseases. AllergyRC581-607ENFrontiers in Immunology, Vol 12 (2021)
institution DOAJ
collection DOAJ
language EN
topic resolution
adaptive immunity
autoimmunity
T cell
therapy
specialized pro-resolving lipid mediators (SPMs)
Immunologic diseases. Allergy
RC581-607
spellingShingle resolution
adaptive immunity
autoimmunity
T cell
therapy
specialized pro-resolving lipid mediators (SPMs)
Immunologic diseases. Allergy
RC581-607
Javier Perez-Hernandez
Javier Perez-Hernandez
Valerio Chiurchiù
Valerio Chiurchiù
Sylvain Perruche
Sylvain Perruche
Sylvaine You
Regulation of T-Cell Immune Responses by Pro-Resolving Lipid Mediators
description Both the initiation and the resolution of inflammatory responses are governed by the sequential activation, migration, and control/suppression of immune cells at the site of injury. Bioactive lipids play a major role in the fine-tuning of this dynamic process in a timely manner. During inflammation and its resolution, polymorphonuclear cells (PMNs) and macrophages switch from producing pro-inflammatory prostaglandins and leukotrienes to specialized pro-resolving lipid mediators (SPMs), namely, lipoxins, resolvins, protectins, and maresins, which are operative at the local level to limit further inflammation and tissue injury and restore homeostasis. Accumulating evidences expand now the role and actions of these lipid mediators from innate to adaptive immunity. In particular, SPMs have been shown to contribute to the control of chronic inflammation, and alterations in their production and/or function have been associated with the persistence of several pathological conditions, including autoimmunity, in human and experimental models. In this review, we focus on the impact of pro-resolving lipids on T cells through their ability to modulate T-cell responses. In particular, the effects of the different families of SPMs to restrain effector T-cell functions while promoting regulatory T cells will be reviewed, along with the underlying mechanisms. Furthermore, the emerging concept of SPMs as new biological markers for disease diagnostic and progression and as putative therapeutic tools to regulate the development and magnitude of inflammatory and autoimmune diseases is discussed.
format article
author Javier Perez-Hernandez
Javier Perez-Hernandez
Valerio Chiurchiù
Valerio Chiurchiù
Sylvain Perruche
Sylvain Perruche
Sylvaine You
author_facet Javier Perez-Hernandez
Javier Perez-Hernandez
Valerio Chiurchiù
Valerio Chiurchiù
Sylvain Perruche
Sylvain Perruche
Sylvaine You
author_sort Javier Perez-Hernandez
title Regulation of T-Cell Immune Responses by Pro-Resolving Lipid Mediators
title_short Regulation of T-Cell Immune Responses by Pro-Resolving Lipid Mediators
title_full Regulation of T-Cell Immune Responses by Pro-Resolving Lipid Mediators
title_fullStr Regulation of T-Cell Immune Responses by Pro-Resolving Lipid Mediators
title_full_unstemmed Regulation of T-Cell Immune Responses by Pro-Resolving Lipid Mediators
title_sort regulation of t-cell immune responses by pro-resolving lipid mediators
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/8c9b52be948d4ead82a8151922b16622
work_keys_str_mv AT javierperezhernandez regulationoftcellimmuneresponsesbyproresolvinglipidmediators
AT javierperezhernandez regulationoftcellimmuneresponsesbyproresolvinglipidmediators
AT valeriochiurchiu regulationoftcellimmuneresponsesbyproresolvinglipidmediators
AT valeriochiurchiu regulationoftcellimmuneresponsesbyproresolvinglipidmediators
AT sylvainperruche regulationoftcellimmuneresponsesbyproresolvinglipidmediators
AT sylvainperruche regulationoftcellimmuneresponsesbyproresolvinglipidmediators
AT sylvaineyou regulationoftcellimmuneresponsesbyproresolvinglipidmediators
_version_ 1718426617105088512